No Data
No Data
Yimai Sunshine (02522.HK) is expected to go public on June 7 and introduce cornerstones such as Lianying Medical
Gelonghui, May 30, 丨 Yimai Sunshine (02522.HK) announced that the company plans to sell 178.16 million shares globally, 1.782 million shares in Hong Kong, China, and 16.34 million shares; the expected pricing date is June 5 from May 30 to June 4, 2024; the sale price will be HK$14.60-16.80 per share, with 500 shares per lot; CITIC Securities is the sole sponsor; it is expected that the shares will start trading on the main board of the Stock Exchange on June 7, 2024. The company is a leading medical imaging specialist medical group in China.
Nomura Adjusts United Imaging Healthcare's Price Target to 139.25 Yuan From 132.88 Yuan, Keeps at Neutral
02:56 AM EDT, 05/24/2024 (MT Newswires) -- Nomura Adjusts United Imaging Healthcare's Price Target to 139.25 Yuan From 132.88 Yuan, Keeps at Neutral
Express News | Race to sea, medical equipment companies discuss development opportunities
Lianying Healthcare (688271): Released 2024 Incentive Plan to Focus on Achieving Long-term Competitiveness
Company News The company issued an announcement on the “2024 Restricted Stock Incentive Plan (Draft)”. The incentive plan plans to grant 2.6219 million restricted shares, accounting for about 0.32% of the company's total share capital of 824 million shares, the first
Lianying Healthcare (688271.SH) appoints Wang Jianbao as the company's financial director
Zhitong Finance App News, Lianying Healthcare (688271.SH) announced that the board of directors of the company recently received the resignation report of TAO CAI, the financial director and chief financial officer, and applied to resign as the company's financial director and chief financial officer due to work reasons. After the resignation, TAO CAI continued to serve as the company's director, board strategy and social responsibility committee member, board secretary and chief investment officer. TAO CAI's resignation report is effective from the date it is delivered to the company's board of directors. Furthermore, the board of directors of the company deliberated and passed the “Proposal on Changing the Company's Financial Officer” on May 21, 2024.
Lianying Healthcare (688271.SH) plans to launch the 2024 Restricted Stock Incentive Plan with an initial grant price of 88 yuan/share
Lianying Healthcare (688271.SH) disclosed the 2024 Restricted Stock Incentive Plan (draft). The incentive plan...
No Data